DIAGNOS



StageZero Life Sciences Ltd.
Latest Comments
image_pdfimage_print

Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market

In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) […]


Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology

CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely […]


Thompson on DIAGNOS and the ‘exploding’ AI healthtech industry

AI Healthcare Provider Diagnos Continues to Sign Deals and Partnerships Amid COVID-19 Crisis Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF […]


Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues

“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are extremely big…” […]


Diagnos’ AI Platform to Fight Vision Loss Continues to Expand Globally

Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) is a software platform provider for the early detection of critical health issues […]


Drolet Stock Notes on Diagnos: AI driven retina analysis tool for the detection of critical health issues

Mario Drolet, President of MI3 Communications Financières Inc. (MI3), released his Drolet Stock Notes on Diagnos Inc. (TSXV: ADK | […]